Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 17/20 | 1.00 |
| ▸ | MMP3 | P08254 | 14/20 | 1.00 |
| ▸ | MMP1 | P03956 | 13/20 | 1.00 |
| ▸ | MMP7 | P09237 | 6/20 | 0.82 |
| ▸ | MMP8 | P22894 | 2/20 | 0.68 |
| ▸ | MMP9 | P14780 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8053894 | 1.00 | MMP2 (1.00) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8057881 | 1.00 | MMP2 (1.00) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8053749 | 1.00 | MMP2 (1.00) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8397172 | 0.90 | MMP2 (1.00) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8396700 | 0.90 | MMP2 (1.00) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8399999 | 0.90 | MMP2 (1.00) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8396703 | 0.90 | MMP2 (1.00) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8400000 | 0.90 | MMP2 (1.00) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8828144 | 0.89 | MMP1 (0.81) | MMP2MMP3MMP1MMP7MMP8 | |
| SCHEMBL8777266 | 0.88 | MMP2 (0.81) | MMP2MMP3MMP1MMP7MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6028110-A | Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 2000-02-22 | — | — | US | claimed |
| EP-0763012-B1 | SUCCINYL HYDROXAMIC ACID, N-FORMYL-N-HYDROXY AMINO CARBOXYLIC ACID AND SUCCINIC ACID AMIDE DERIVATIVES AS METALLOPROTEASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1999-06-09 | — | — | EP | claimed |
| US-6028110-A | Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 2000-02-22 | — | — | US | disclosed |
| EP-0763012-B1 | SUCCINYL HYDROXAMIC ACID, N-FORMYL-N-HYDROXY AMINO CARBOXYLIC ACID AND SUCCINIC ACID AMIDE DERIVATIVES AS METALLOPROTEASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1999-06-09 | — | — | EP | disclosed |